Early trial aims to boost Radiation's power against brain tumors
NCT ID NCT02015117
Summary
This early-stage study is testing whether adding a drug called trametinib to standard whole-brain radiation therapy is safe and effective for treating cancer that has spread to the brain. The main goals are to find the safest dose of the drug and to see how much of it reaches the brain tumors. Researchers hope the drug will make the cancer cells more sensitive to the radiation, potentially leading to better control of the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MALIGNANT NEOPLASM IN THE BRAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.